Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: A systematic review and meta-analysis

Clinical Chemistry and Laboratory Medicine

Volumn 54, Issue 1, 2016, Pages 7-15

  Braga, Federica ^a   Pasqualetti, Sara ^a   Ferraro, Simona ^a   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

coronary heart disease; meta analysis; uric acid

Indexed keywords

URATE; URIC ACID;

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; FOLLOW UP; GROUPS BY AGE; HUMAN; HYPERURICEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; OBSERVATIONAL STUDY; PEER REVIEW; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SAMPLE SIZE; SEX DIFFERENCE; SYSTEMATIC REVIEW; URIC ACID URINE LEVEL; BLOOD; CORONARY DISEASE; META ANALYSIS; MORTALITY; RISK FACTOR;

COHORT STUDIES; CORONARY DISEASE; HUMANS; HYPERURICEMIA; RISK FACTORS; URIC ACID;

EID: 84954338917     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0523     Document Type: Review

References (43)

1. Lamb JE, Price CP. Kidney function tests. Uric acid. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics, 5th ed. St. Louis: Elsevier Saunders, 2012:686-91.
2. Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 2013;99:759-66.
3. Wheeler JG, Juzwishin KD, Eiriksdottir G, Gudnason V, Danesh J. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2005;2:e76.
4. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: A systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010;62:170-80.
5. Zhao G, Huang L, Song M, Song Y. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: A meta-analysis of prospective studies. Atherosclerosis 2013;231:61-8.
6. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359:1811-21.
7. Erratum in: N Engl J Med 2010;362:2235.
8. Akkineni R, Tapp S, Tosteson AN, Lee A, Miller KL, Choi HK, et al. Treatment of asymptomatic hyperuricemia and prevention of vascular disease: A decision analytic approach. J Rheumatol 2014;41:739-48.
9. Kanbay M, Solak Y, Gaipov A, Takir M, Weiner DE. Allopurinol as a kidney-protective, cardioprotective, and antihypertensive agent: hype or reality? Blood Purif 2014;37:172-8.
10. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. J Am Med Assoc 1999;282:1054-60.
11. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: A proposal for reporting. J Am Med Assoc 2000;283:2008-12.
12. Goldberg RJ, Burchfiel CM, Benfante R, Chiu D, Reed DM, Yano K. Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-year findings from the Honolulu Heart Program. Arch Intern Med 1995;155:686-94.
13. Iribarren C, Sharp DS, Curb JD, Yano K. High uric acid: A metabolic marker of coronary heart disease among alcohol abstainers. J Clin Epidemiol 1996;49:673-8.
14. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 1999;131:7-13.
15. Liese AD, Hense HW, Löwel H, Döring A, Tietze M, Keil U. Association of serum uric acid with all cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. Epidemiology 1999;10:391-7.
16. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000;10:136-43.
17. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam study. Stroke 2006;37:1503-7.
18. Baba T, Amasaki Y, Soda M, Imaizumi M, Ichimaru S, Nakashima E, et al. Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki. Hypertens Res 2007;30:823-9.
19. Meisinger C, Koenig W, Baumert J, Doring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: The MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008;28:1186-92.
20. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009;266:558-70.
21. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995;141:637-44.
22. Jee SH, Lee SY, Kim MT. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prev Rehabil 2004;11:185-91.
23. Gerber Y, Tanne D, Medalie JH, Goldbourt U. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil 2006;13:193-8.
24. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. Serum uric acid and risk of cardiovascular mortality: A prospective long-term study of 83 683 Austrian men. Clin Chem 2008;54:273-84.
25. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study. Int J Cardiol 2008;125:232-9.
26. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A Chinese cohort study. Arthritis Rheum 2009;61:225-32.
27. Persky VW, Dyer AR, Idris-Soven E, Stamler J, Shekelle RB, Schoenberger JA, et al. Uric acid: A risk factor for coronary heart disease? Circulation 1979;59:969-77.
28. Petersson B, Trell E. Raised serum urate concentration as risk factor for premature mortality in middle aged men: relation to death from cancer. Br Med J 1983;287:7-9.
29. Levine W, Dyer AR, Shekelle R, Schoenberger J, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989;42:257-67.
30. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992: National Health and Nutrition Examination Survey. J Am Med Assoc 2000;283:2404-10.
31. Puddu PE, Lanti M, Menotti A, Mancini M, Zanchetti A, Cirillo M, et al. Serum uric acid for short-term prediction of cardio-vascular disease incidence in the Gubbio Population Study. Acta Cardiol 2001;56:243-51.
32. Aboa Eboule A, de Smet P, Dramaix M, de Backer G, Kornitzer M. Relation between uricemia and all-causes cardiovascular and coronary mortality in both genders of non-selected sample of the Belgium population. Rev Epidemiol Sante Publique 2001;49:531-9.
33. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT, et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2005;183:147-55.
34. Baibas N, Trichopoulou A, Voridis E, Trichopoulos D. Residence in mountainous compared with lowland areas in relation to total and coronary mortality: A study in rural Greece. J Epidemiol Community Health 2005;59:274-8.
35. Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, et al. Serum uric acid concentration as a risk factor for cardiovascular mortality: A long term cohort study of atomic bomb survivors. J Rheumatol 2005;32:906-12.
36. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688-96.
37. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH, and the MRFIT Research Group. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008;168:1104-10.
38. Chandra NC, Ziegelstein RC, Rogers WJ, Tiefenbrunn AJ, Gore JM, French WJ, et al. Observations of the treatment of women in the United States with myocardial infarction: A report from the National Registry of Myocardial Infarction-I. Arch Intern Med 1998;158:981-8.
39. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-151.
40. Erratum in: Circulation 2006;113:e696
41. Circulation 2006;114:e630.
42. Soler EP, Ruiz VC. Epidemiology and risk factors of cerebral ischemia and ischemic heart disease: similarities and differences. Curr Cardiol Rev 2010;6:138-49.
43. Ministero della Salute. La situazione sanitaria del Paese. Malattie. Available from: http://www.salute.gov.it/imgs/C-17-navigazioneSecondariaRelazione-1-listaCapitoli-capitoliItem-Name-1-scarica.pdf. Accessed 27 March, 2015.